Boris Bastian, MD, Pathology, San Francisco, CA

BorisChristianBastianMD

Pathology San Francisco, CA

Professor of Dermatology, UCSF

Are you Dr. Bastian?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 10 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Boris Bastian, MD is a pathologist in San Francisco, California. He is currently licensed to practice medicine in California and New York. He is a Professor of Dermatology at UCSF.

Education & Training

  • Ludwig Maximilian University of Munich Faculty of Medicine
    Ludwig Maximilian University of Munich Faculty of MedicineClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - Present
  • CA State Medical License
    CA State Medical License 2001 - 2021

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2012
  • America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2011

Publications & Presentations

PubMed

Press Mentions

  • Evolution of Melanoma Reveals Opportunities for Intervention
    Evolution of Melanoma Reveals Opportunities for InterventionJuly 10, 2018 17:53
  • Correcting a Blind Spot
    Correcting a Blind SpotJuly 03, 2018 18:01
  • American Skin Association Announces Abby S. And Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma Skin Cancer Research
    American Skin Association Announces Abby S. And Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma Skin Cancer ResearchApril 18, 2018 11:40
  • Join now to see all

Grant Support

  • The KIT Signaling Pathway As A Therapeutic Target In MelanomaNational Cancer Institute2011–2012
  • The GNAQ Pathway As A Therapeutic Target In Uveal MelanomaNational Cancer Institute2010–2012
  • The GNAQ Pathway As A Therapeutic Target In Uveal MelanomaNational Cancer Institute2011
  • Biomarker Discovery For The Classification Of MelanomaNational Cancer Institute2010–2011
  • Biomarker Discovery For The Classification Of MelanomaNational Cancer Institute2008–2011
  • Genetic Expression Of Lentigo Malignant Melanoma - UCSF ConsortiumNational Cancer Institute2007–2009
  • Genomic Analysis Of Squamous Cell CarcinomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2007
  • Genetic Expression Of Lentigo Malignant Melanoma, Proj. 2 - UCSF ConsortiumNational Cancer Institute2005–2006
  • Classification Of Ambiguous Melanocytic TumorsNational Cancer Institute2002–2005